Skip to content
Back to News

PathAI Advances AISight® Dx with the v2.20 Release: Enhancing Viewer Usability, Workflow Efficiency, and Platform Reliability

We're thrilled to announce the release of AISight® Dx v2.20, the latest update to PathAI's FDA-cleared digital pathology image management system. At PathAI, every release is driven by one goal: making digital pathology work better for the people who depend on it every day. This update reflects direct feedback from our users and our ongoing commitment to removing friction from clinical workflows, so pathologists and lab teams can stay focused on what matters most.

v2.20 delivers a more intuitive Slide Viewer experience, smarter workflow controls, and expanded storage and archiving capabilities, including a new right-click context menu for faster access to tools, one-click visibility toggling for all slide data, and flexible self-service options for slide tray organization and archived slide restoration. As we continue to evolve AISight Dx, our focus remains on building a platform that is not only powerful and scalable, but genuinely easier to use at every step.

 

A More Efficient Tool Engagement

We know that every second in the Slide Viewer counts. With v2.20, users gain access to a right-click context menu that surfaces the tools they need, including annotations, snapshots, fullscreen mode, and more, without breaking their review flow. A single action now toggles all markups, fields and annotations on or off, giving users full control over what they see and when.

Screenshot 2026-05-11 at 10.26.40 AMFigure 1: Functional right-click menu in the slide viewer

 

In addition, the Navigation Bar has been modernized, allowing customers to navigate through the same pages as before with a fresh look. 

Screenshot 2026-05-11 at 10.34.52 AM

Figure 2: Refreshed navigation bar

 

Smarter Workflow, Less Noise

Clarity in the workspace drives better decisions. Rejected algorithm results no longer appear in the Slide Tray, keeping the view focused on what is actionable. Thumbnails for annotations and fields of interest now reflect the same orientation shown in the Slide Viewer, eliminating a small but persistent source of friction. Slide tray cards have been updated for a cleaner, more readable layout.

Screenshot 2026-05-11 at 10.37.31 AM

Figure 3: Data thumbnail orientation

 

Storage and Archiving Built for Real Operations

As labs scale, so does the complexity of managing slide data. Resident users can now restore individual archived slides without restoring an entire accession, a meaningful time-saver in day-to-day operations. This capability is designed to reduce administrative burden and keep lab operations running cleanly as digital pathology volume grows.

 

A More Reliable Platform

Reliability is not a feature, it is a foundation. This release includes targeted fixes addressing AISight Live session behavior, snapshot annotation rendering on retina displays, Escape key consistency across the Slide Viewer, specimen merge handling, and an "Add to Folder" dialog display issue. Each fix is a direct response to user-reported friction, and each one reflects our commitment to a platform that performs consistently, every time.

 

Configurable Features

v2.20 introduces a new layer of configurability, giving both organizations and individual users greater control over how the platform works for them.

At the organization level, sites can now configure automatic deletion of empty shell accessions and apply existing storage transition rules to unassigned slides across the lab, reducing administrative overhead as digital pathology volume grows.

At the individual user level, the slide navigator can be resized to take up less screen space, and users can choose to organize their slide tray by Specimen/Block or by Slide ID directly from User Preferences.

Screenshot 2026-05-11 at 10.41.14 AM

Figure 4: Slide navigator size

 

v2.20 is another step in PathAI’s continued investment in the AISight Dx IMS Platform, and we are just getting started.

To explore these updates or schedule a walkthrough with our team, reach out at digitaldx@pathai.com or schedule a demo here.

AISight® Dx is FDA-cleared for primary diagnosis in the US and is CE‑IVD–marked for primary diagnosis in the EEA, UK, and Switzerland.

pathai-0405

Get In Touch

PathAI Media

Company Contact

Liz Storti

Chief People Officer

elizabeth.storti@pathai.com

Media Contact

Daniel Donato

LifeSci Communications

ddonato@lifescicomms.com

516-474-0554